Yuliang Liu

CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia

Ying Sun, De-guang Sun, Huan Wang, 2017, Journal of Cancer.

A Highly Sensitive and Specific Detection Method for Mycobacterium tuberculosis Fluoroquinolone Resistance Mutations Utilizing the CRISPR-Cas13a System

H. Deng, Yuan Hu, Q. Long, 2022, Frontiers in Microbiology.

NQO1 bioactivatable drugs enhance radiation responses

Jinming Gao, D. Boothman, R. Brekken, 2016 .

Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone

R. Deberardinis, D. Gerber, Jinming Gao, 2015, Scientific Reports.

Engineered Split-TET2 Enzyme for Inducible Epigenetic Remodeling

Minyong Li, Deqiang Sun, Yubin Zhou, 2017, Journal of the American Chemical Society.